Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6669392
[patent_doc_number] => 20030114376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Drugs for ameliorating retinal function'
[patent_app_type] => new
[patent_app_number] => 10/204582
[patent_app_country] => US
[patent_app_date] => 2002-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2909
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20030114376.pdf
[firstpage_image] =>[orig_patent_app_number] => 10204582
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/204582 | Drugs for ameliorating retinal function | Sep 18, 2002 | Abandoned |
Array
(
[id] => 1073767
[patent_doc_number] => 06838432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-01-04
[patent_title] => 'Treatment of sepsis with TAFI'
[patent_app_type] => utility
[patent_app_number] => 10/246662
[patent_app_country] => US
[patent_app_date] => 2002-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 0
[patent_no_of_words] => 10669
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/838/06838432.pdf
[firstpage_image] =>[orig_patent_app_number] => 10246662
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/246662 | Treatment of sepsis with TAFI | Sep 17, 2002 | Issued |
Array
(
[id] => 7224450
[patent_doc_number] => 20040072744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Synthetic peptide as treatment for down\'s syndrome and schizophrenia'
[patent_app_type] => new
[patent_app_number] => 10/242175
[patent_app_country] => US
[patent_app_date] => 2002-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5198
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10242175
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/242175 | Synthetic peptide as treatment for down's syndrome and schizophrenia | Sep 11, 2002 | Abandoned |
Array
(
[id] => 720132
[patent_doc_number] => 07049286
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-23
[patent_title] => 'Insulin conjugates and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/231894
[patent_app_country] => US
[patent_app_date] => 2002-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 14284
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/049/07049286.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231894
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231894 | Insulin conjugates and methods of use thereof | Aug 28, 2002 | Issued |
Array
(
[id] => 10013082
[patent_doc_number] => 09056087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-16
[patent_title] => 'Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/488084
[patent_app_country] => US
[patent_app_date] => 2002-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2608
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10488084
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/488084 | Methods of healing or preventing inflammation, damage and other changes that occur prior to, during or immediately after a myocardial event with thymosin beta 4, analogues, isoforms and other derivatives | Aug 28, 2002 | Issued |
Array
(
[id] => 6765689
[patent_doc_number] => 20030100089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'Serine protease inhibitor and processes for the preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/228830
[patent_app_country] => US
[patent_app_date] => 2002-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7789
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20030100089.pdf
[firstpage_image] =>[orig_patent_app_number] => 10228830
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/228830 | Serine protease inhibitor and processes for the preparation thereof | Aug 26, 2002 | Abandoned |
Array
(
[id] => 463562
[patent_doc_number] => 07238663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-07-03
[patent_title] => 'Pre-mixes of GLP-1 and basal insulin'
[patent_app_type] => utility
[patent_app_number] => 10/486333
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 19551
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/238/07238663.pdf
[firstpage_image] =>[orig_patent_app_number] => 10486333
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/486333 | Pre-mixes of GLP-1 and basal insulin | Aug 22, 2002 | Issued |
Array
(
[id] => 931219
[patent_doc_number] => 06979723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-12-27
[patent_title] => 'Process for preparing glycopeptide phosphonate derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/226428
[patent_app_country] => US
[patent_app_date] => 2002-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6072
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 329
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/979/06979723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10226428
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/226428 | Process for preparing glycopeptide phosphonate derivatives | Aug 22, 2002 | Issued |
Array
(
[id] => 6740725
[patent_doc_number] => 20030158094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Combination product of an aryl-substituted propanolamine derivative with at least one other active ingredient and the use of the product'
[patent_app_type] => new
[patent_app_number] => 10/225802
[patent_app_country] => US
[patent_app_date] => 2002-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7088
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158094.pdf
[firstpage_image] =>[orig_patent_app_number] => 10225802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/225802 | Combination product of an aryl-substituted propanolamine derivative with at least one other active ingredient and the use of the product | Aug 21, 2002 | Abandoned |
Array
(
[id] => 6847777
[patent_doc_number] => 20030166944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme'
[patent_app_type] => new
[patent_app_number] => 10/223590
[patent_app_country] => US
[patent_app_date] => 2002-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14611
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166944.pdf
[firstpage_image] =>[orig_patent_app_number] => 10223590
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/223590 | TRH-like peptide derivatives as inhibitors of the TRH-degrading ectoenzyme | Aug 18, 2002 | Abandoned |
Array
(
[id] => 7127840
[patent_doc_number] => 20050059584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Novel chemokine mimetics synthesis and their use'
[patent_app_type] => utility
[patent_app_number] => 10/222703
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 57497
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059584.pdf
[firstpage_image] =>[orig_patent_app_number] => 10222703
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/222703 | Novel chemokine mimetics synthesis and their use | Aug 15, 2002 | Abandoned |
Array
(
[id] => 7314174
[patent_doc_number] => 20040033940
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-19
[patent_title] => 'Cyclic hepta-peptide derivative from colonial ascidians, lissoclinum SP'
[patent_app_type] => new
[patent_app_number] => 10/223024
[patent_app_country] => US
[patent_app_date] => 2002-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2654
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20040033940.pdf
[firstpage_image] =>[orig_patent_app_number] => 10223024
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/223024 | Cyclic hepta-peptide derivative from colonial ascidians, lissoclinum SP | Aug 15, 2002 | Abandoned |
Array
(
[id] => 6847400
[patent_doc_number] => 20030166567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => 'Anti-aging and wound healing compounds'
[patent_app_type] => new
[patent_app_number] => 10/219561
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 23661
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 64
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166567.pdf
[firstpage_image] =>[orig_patent_app_number] => 10219561
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/219561 | Anti-aging and wound healing compounds | Aug 14, 2002 | Issued |
Array
(
[id] => 6801592
[patent_doc_number] => 20030096757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Anti-cancer and wound healing compounds'
[patent_app_type] => new
[patent_app_number] => 10/219329
[patent_app_country] => US
[patent_app_date] => 2002-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22122
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096757.pdf
[firstpage_image] =>[orig_patent_app_number] => 10219329
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/219329 | Anti-cancer and wound healing compounds | Aug 14, 2002 | Issued |
Array
(
[id] => 6673827
[patent_doc_number] => 20030059430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'IGF-binding protein-derived peptide or small molecule'
[patent_app_type] => new
[patent_app_number] => 10/215759
[patent_app_country] => US
[patent_app_date] => 2002-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13924
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059430.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215759
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215759 | IGF-binding protein-derived peptide | Aug 8, 2002 | Issued |
Array
(
[id] => 6818226
[patent_doc_number] => 20030069184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Antifungal and antibacterial agents'
[patent_app_type] => new
[patent_app_number] => 10/215168
[patent_app_country] => US
[patent_app_date] => 2002-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 8287
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069184.pdf
[firstpage_image] =>[orig_patent_app_number] => 10215168
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/215168 | Antifungal and antibacterial agents | Aug 7, 2002 | Issued |
Array
(
[id] => 903609
[patent_doc_number] => 07335723
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-26
[patent_title] => 'Melanin-concentrating hormone antagonists'
[patent_app_type] => utility
[patent_app_number] => 10/485682
[patent_app_country] => US
[patent_app_date] => 2002-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7830
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/335/07335723.pdf
[firstpage_image] =>[orig_patent_app_number] => 10485682
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/485682 | Melanin-concentrating hormone antagonists | Aug 1, 2002 | Issued |
Array
(
[id] => 6865667
[patent_doc_number] => 20030191193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Lactoferrin'
[patent_app_type] => new
[patent_app_number] => 10/205960
[patent_app_country] => US
[patent_app_date] => 2002-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4811
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205960
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205960 | Lactoferrin | Jul 25, 2002 | Abandoned |
Array
(
[id] => 6869982
[patent_doc_number] => 20030082671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Method for making acylated polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/205270
[patent_app_country] => US
[patent_app_date] => 2002-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6518
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082671.pdf
[firstpage_image] =>[orig_patent_app_number] => 10205270
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/205270 | Method for making acylated polypeptides | Jul 23, 2002 | Abandoned |
10/070598 | Method for reducing the risk of cancer | Jul 22, 2002 | Abandoned |